Qin Li, Mao Jieling, Gao Min, Xie Jingwen, Liang Zhikun, Li Xiaoyan
Department of Pharmacy, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Front Pharmacol. 2024 Nov 20;15:1478342. doi: 10.3389/fphar.2024.1478342. eCollection 2024.
Due to its complex pathogenesis, the assessment of cancer-associated disseminated intravascular coagulation (DIC) is challenging. We aimed to develop a machine learning (ML) model to predict overt DIC in critically ill colorectal cancer (CRC) patients using clinical features and laboratory indicators.
This retrospective study enrolled consecutive CRC patients admitted to the intensive care unit from January 2018 to December 2023. Four ML algorithms were used to construct predictive models using 5-fold cross-validation. The models' performance in predicting overt DIC and 30-day mortality was evaluated using the area under the receiver operating characteristic curve (ROC-AUC) and Cox regression analysis. The performance of three established scoring systems, ISTH DIC-2001, ISTH DIC-2018, and JAAM DIC, was also assessed for survival prediction and served as benchmarks for model comparison.
A total of 2,766 patients were enrolled, with 699 (25.3%) diagnosed with overt DIC according to ISTH DIC-2001, 1,023 (36.9%) according to ISTH DIC-2018, and 662 (23.9%) according to JAAM DIC. The extreme gradient boosting (XGB) model outperformed others in DIC prediction (ROC-AUC: 0.848; 95% CI: 0.818-0.878; < 0.01) and mortality prediction (ROC-AUC: 0.708; 95% CI: 0.646-0.768; < 0.01). The three DIC scores predicted 30-day mortality with ROC-AUCs of 0.658 for ISTH DIC-2001, 0.692 for ISTH DIC-2018, and 0.673 for JAAM DIC.
The results indicate that ML models, particularly the XGB model, can serve as effective tools for predicting overt DIC in critically ill CRC patients. This offers a promising approach to improving clinical decision-making in this high-risk group.
由于其发病机制复杂,癌症相关的弥散性血管内凝血(DIC)评估具有挑战性。我们旨在开发一种机器学习(ML)模型,利用临床特征和实验室指标预测重症结直肠癌(CRC)患者的显性DIC。
这项回顾性研究纳入了2018年1月至2023年12月期间入住重症监护病房的连续CRC患者。使用四种ML算法,通过五折交叉验证构建预测模型。使用受试者工作特征曲线下面积(ROC-AUC)和Cox回归分析评估模型在预测显性DIC和30天死亡率方面的性能。还评估了三种既定评分系统(ISTH DIC-2001、ISTH DIC-2018和JAAM DIC)在生存预测方面的性能,并将其作为模型比较的基准。
共纳入2766例患者,根据ISTH DIC-2001诊断为显性DIC的有699例(25.3%),根据ISTH DIC-2018诊断为显性DIC的有1023例(36.9%),根据JAAM DIC诊断为显性DIC的有662例(23.9%)。极端梯度提升(XGB)模型在DIC预测(ROC-AUC:0.848;95%CI:0.818-0.878;<0.01)和死亡率预测(ROC-AUC:0.708;95%CI:0.646-0.768;<0.01)方面优于其他模型。三种DIC评分预测30天死亡率的ROC-AUC分别为:ISTH DIC-2001为0.658,ISTH DIC-2018为0.692,JAAM DIC为0.673。
结果表明,ML模型,特别是XGB模型,可作为预测重症CRC患者显性DIC的有效工具。这为改善这一高危人群的临床决策提供了一种有前景的方法。